FDA Project Optimus: The “Right Dose” in Oncology Drug Development
Oncology drug development is undergoing a fundamental methodological transformation. With the launch of Project Optimus in 2021, the U.S. Food and Drug Administration (FDA) formally signaled that the historical paradigm centered on identifying the maximum tolerated dose (MTD) is no...
